3 May 2024 - Thousands of patients with sickle cell disorder are to be offered a new “life-changing” treatment on the NHS from today, following the approval and roll-out of a new drug that could significantly improve their quality of life.

Up to 4,000 people with sickle cell disease in England could benefit from the drug voxelotor if recommended by their clinician, which will offer an additional treatment option from today, following its approval by the National Institute for Health and Care Excellence (NICE).

Read NHS England press release